Mather Group’s Globus Medical GMED Stock Holding History

Mather Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$22.4K	Hold	299	–	–	﹤0.01%	1403
2026 Q2	$23.6K	Sell	299 -6	-2%	-$510	﹤0.01%	1290
2026 Q1	$26.3K	Buy	+305	New	+$27.4K	﹤0.01%	1217
2025 Q4	–	Sell	-395	Closed	-$22.6K	–	1041
2025 Q3	$22.6K	Buy	+395	New	+$22.7K	﹤0.01%	1091
2025 Q2	–	Sell	-1,417	Closed	-$104K	–	1051
2025 Q1	$104K	Buy	1,417 +61	+4%	+$5.04K	﹤0.01%	740
2024 Q4	$112K	Buy	1,356 +190	+16%	+$15K	﹤0.01%	711
2024 Q3	$83.4K	Sell	1,166 -165	-12%	-$11.6K	﹤0.01%	776
2024 Q2	$71.4K	Buy	1,331 +34	+3%	+$2.03K	﹤0.01%	908
2024 Q1	$69.1K	Buy	+1,297	New	+$69.7K	﹤0.01%	802

Other funds holding GMED

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $809M AUM 17.64% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

Covea Finance Paris, France $3.07B AUM 27.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Mather Group's GMED Position: Q3 2026 in Review

Mather Group held its Globus Medical (GMED) position steady in Q3 2026 at 299 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

Mather Group first reported a position in GMED in Q1 2024 and has held it in 9 quarters since. The position peaked at $112K in Q4 2024. 108 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

Mather Group held 299 shares of Globus Medical worth $22.4K as of Q3 2026.
Mather Group left its Globus Medical share count unchanged in Q3 2026.
Globus Medical made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1403 holding.
Mather Group first reported a position in Globus Medical in Q1 2024 and has held it in 9 quarters since.
Mather Group's Globus Medical position peaked at $112K in Q4 2024.
108 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.